Tissue Regenix Group PLC (LON:TRX) is on the hunt for a new chief financial officer after Ian Jefferson handed in his notice.
Jefferson will remain available to the regenerative medical devices company while the search for his successor takes place, and will also be on hand to bed in his replacement.
“We would like to thank Ian for his commitment to Tissue Regenix over the last five years, and we wish him all the best in the future," said Antony Odell, chief executive officer of Tissue Regenix.